OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Spike Protein Fragments Promote Alzheimer’s Amyloidogenesis
Sujian Cao, Zhiyuan Song, Jinyu Rong, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 34, pp. 40317-40329
Open Access | Times Cited: 12

Showing 12 citing articles:

Determinants for Substoichiometric Inhibition of IAPP and Aβ Amyloid Aggregations by Bri2 BRICHOS
Zhenzhen Zhang, Gangtong Huang, Shivani Gupta, et al.
ACS Chemical Neuroscience (2025)
Closed Access

Deciphering the Morphological Difference of Amyloid-β Fibrils in Familial and Sporadic Alzheimer’s Diseases
Gangtong Huang, Zhiyuan Song, Yun Xu, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 20, pp. 8024-8033
Closed Access | Times Cited: 4

Silver nanoparticles alter the dimerization of Aβ42 studied by REMD simulations
Quynh Mai Thai, Phuong‐Thao Tran, Hường Thị Thu Phùng, et al.
RSC Advances (2024) Vol. 14, Iss. 21, pp. 15112-15119
Open Access | Times Cited: 3

Promising Strategies to Reduce the SARS-CoV-2 Amyloid Deposition in the Brain and Prevent COVID-19-Exacerbated Dementia and Alzheimer’s Disease
Nikita Navolokin, Viktoria Adushkina, Daria Zlatogorskaya, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 788-788
Open Access | Times Cited: 3

COVID-19 and Alzheimer’s Disease Share Common Neurological and Ophthalmological Manifestations: A Bidirectional Risk in the Post-Pandemic Future
Giuseppina Amadoro, Valentina Latina, Egidio Stigliano, et al.
Cells (2023) Vol. 12, Iss. 22, pp. 2601-2601
Open Access | Times Cited: 9

Viral amyloids: New opportunities for antiviral therapeutic strategies
Frank Gondelaud, Pierre‐Yves Lozach, Sonia Longhi
Current Opinion in Structural Biology (2023) Vol. 83, pp. 102706-102706
Open Access | Times Cited: 8

COVID‐19 and cognitive impairment: From evidence to SARS‐CoV‐2 mechanism
Haodong Pan, Jing-Yan Niu, Feng Lin, et al.
Brain‐X (2024) Vol. 2, Iss. 2
Open Access | Times Cited: 2

Islet amyloid polypeptide fibril catalyzes amyloid-β aggregation by promoting fibril nucleation rather than direct axial growth
Zhiyuan Song, Huayuan Tang, Adam J. Gatch, et al.
International Journal of Biological Macromolecules (2024) Vol. 279, pp. 135137-135137
Closed Access | Times Cited: 1

SARS-CoV-2 Spike amyloid fibrils specifically and selectively accelerates amyloid fibril formation of human prion protein and the amyloid β peptide
Johan N. K. Larsson, Ebba Hellstrand, Per Hammarström, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3

Cell invasive amyloid assemblies from SARS-CoV-2 peptides can form multiple polymorphs with varying neurotoxicity
Oana Sanislav, Rina Tetaj, Metali, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

TDP-43 Promotes Amyloid-Beta Toxicity by Delaying Fibril Maturation via Direct Molecular Interaction
Adam J. Gatch, Feng Ding
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 15, pp. 2936-2953
Closed Access

Page 1

Scroll to top